Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
1.790
-0.070 (-3.76%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Tenax Therapeutics Market Cap
Tenax Therapeutics has a market cap or net worth of $102.53 million as of October 30, 2026. It is the 24,849th most valuable company in the world and the 4,068th biggest in the United States. Its market cap has decreased by 64.54% in one year.
Market Cap
102.53M
Enterprise Value
-15.44M
1-Year Change
-64.54%
Global Rank
Country Rank
#4,068 United States
Category
ChartMarket Cap Chart
Since March 16, 1993, Tenax Therapeutics's market cap has decreased from $110.17M to $102.53M, a decrease of -6.93%. That is a compound annual growth rate of -0.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 102.53M | -79.27% |
| Dec 31, 2025 | 494.55M | 126.39% |
| Dec 31, 2024 | 218.45M | 3,233.86% |
| Dec 29, 2023 | 6.55M | 31.60% |
| Dec 30, 2022 | 4.98M | -81.01% |
| Dec 31, 2021 | 26.21M | 11.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OnKure Therapeutics | 106.10M |
| Voyager Therapeutics | 105.98M |
| PDS Biotechnology | 104.36M |
| Unicycive Therapeutics | 104.18M |
| Milestone Pharmaceuticals | 102.86M |
| enGene Therapeutics | 102.53M |
| Immunic | 102.47M |
| Tiziana Life Sciences | 102.42M |